文献速递复苏、休克与脓毒症

新加坡住宅与非住宅院外心脏骤停的全国趋势及旁观者心肺复苏差异

Nationwide trends in residential and non-residential out-of-hospital cardiac arrest and differences in bystander cardiopulmonary resuscitation.
PubMed 文献 · Resuscitation · 2020-03-23
一句话结论新加坡2010至2016年住宅院外心脏骤停的旁观者心肺复苏率与旁观者自动体外除颤器使用率均低于非住宅事件,出院生存率更低(2.9% vs 10.1%),住宅事件为独立不良生存因素(调整OR 0.547)。

该全国性观察性研究利用泛亚洲复苏结局研究前瞻性数据,分析新加坡2010至2016年8397例院外心脏骤停,其中住宅事件5990例(71.3%)。住宅事件的旁观者心肺复苏率(41.0% vs 53.6%)和旁观者自动体外除颤器使用率(0.4% vs 10.8%)均显著低于非住宅事件,出院生存率亦更低(2.9% vs 10.1%)。多因素逻辑回归显示住宅地点对生存有独立影响(调整OR 0.547 [0.435-0.688])。住宅事件的旁观者心肺复苏率从2010年15.8%升至2016年57.1%,且随全市干预推进,住宅与非住宅事件间旁观者心肺复苏率差异逐年缩小(交互作用显著)。

要点

  • 住宅院外心脏骤停占71.3%(5990/8397),其旁观者心肺复苏率41.0%显著低于非住宅53.6%(p<0.01)。
  • 住宅事件旁观者自动体外除颤器使用率仅0.4%,远低于非住宅10.8%(p<0.01)。
  • 住宅事件出院生存率2.9%,显著低于非住宅10.1%(p<0.01);调整OR 0.547 [0.435-0.688]。
  • 住宅事件旁观者心肺复苏率从2010年15.8%升至2016年57.1%,与非住宅差异逐年缩小(交互作用显著)。

适用人群与场景

  • 新加坡2010至2016年院外心脏骤停患者,共8397例纳入分析,其中住宅事件5990例(71.3%)。
  • 数据来自泛亚洲复苏结局研究前瞻性登记,为全国性观察性研究。

研究设计与关键结果

  • 研究类型:全国性观察性研究,使用泛亚洲复苏结局研究前瞻性数据,2010至2016年新加坡,8397例纳入分析。
  • 住宅事件5990例(71.3%);住宅事件旁观者心肺复苏率41.0% vs 非住宅53.6%(p<0.01),旁观者自动体外除颤器使用率0.4% vs 10.8%(p<0.01)。
  • 住宅事件出院生存率2.9% vs 非住宅10.1%(p<0.01);多因素逻辑回归显示住宅地点对生存有独立影响(调整OR 0.547 [0.435-0.688])。
  • 住宅事件旁观者心肺复苏率从2010年15.8%升至2016年57.1%;年份与地点类型对旁观者心肺复苏存在显著交互作用,住宅与非住宅间旁观者心肺复苏率差异逐年缩小。

证据类型、等级与局限

  • 证据类型:全国性观察性研究(前瞻性登记数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管全市干预使住宅事件旁观者心肺复苏率提升更多、与非住宅差异缩小,但住宅事件旁观者干预与生存仍较差,提示需针对住宅场景强化旁观者心肺复苏与自动体外除颤器可及性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIMS: Singapore is highly-urbanized, with >90% of the population living in high-rise apartments. She has implemented several city-wide interventions such as dispatcher-assisted CPR, community CPR training and smartphone activation of volunteers to increase bystander CPR (BCPR) rates for out-of-hospital cardiac arrest (OHCA). These may have different impact on residential and non-residential OHCA. We aimed to evaluate the characteristics, processes-of-care and outcome differences between residential and non-residential OHCA and study the differences in temporal trends of BCPR rates.

METHODS: This was a national, observational study in Singapore from 2010 to 2016, using data from the prospective Pan-Asian Resuscitation Outcomes Study. The primary outcome was survival (to-discharge or to-30-days). Multivariate logistic regression was performed to determine the effect of location-type on survival and a test of statistical interaction was performed to assess the difference in the temporal relationship of BCPR rates between location-type.

RESULTS: 8397 cases qualified for analysis, of which 5990 (71.3%) were residential. BCPR and bystander automated external defibrillator (AED) rates were significantly lower in residential as compared to non-residential arrests (41.0% vs 53.6%, p < 0.01; 0.4% vs 10.8%, p < 0.01 respectively). Residential BCPR increased from 15.8% (2010) to 57.1% (2016). Residential cardiac arrests had lower survival-to-discharge (2.9% vs 10.1%, p < 0.01). Multivariate logistic regression analysis showed that location-type had an independent effect on survival, with residential arrests having poorer survival compared to non-residential cardiac arrests (adjusted OR 0.547 [0.435-0.688]). A test of statistical interaction showed a significant interaction effect between year and location-type for bystander CPR, with a narrowing of differences in bystander CPR between residential and non-residential cardiac arrests over the years.

CONCLUSION: Residential cardiac arrests had poorer bystander intervention and survival from 2010 to 2016 in Singapore. BCPR had improved more in residential arrests compared to non-residential arrests over a period of city-wide interventions to improve BCPR.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Ting PZY, Ho AFW, Lin X, et al. Nationwide trends in residential and non-residential out-of-hospital cardiac arrest and differences in bystander cardiopulmonary resuscitation. Resuscitation. 2020. PMID: 32217133. doi:10.1016/j.resuscitation.2020.03.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。